menu
    • menu

    Company profile for JCR Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    JCR is a specialty pharma engaged in the research, development, manufacture and marketing of biopharmaceuticals and regenerative medicine with a focus on rare diseases. Its philosophy, “Contributing towards people’s healthcare through pharmaceutical products” drives JCR to create innovative pharmaceutical products as value-added treatment options for the under-served patient communities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    JCR Pharmaceuticalsjapan Flag
    Country
    Country
    Japan
    Address
    Address
    3-19　Kasuga-cho　Ashiya,　Hyogo, 659-0021
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jcrpharm.co.jp/en/site/en/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JCR Pharma Launches Into Next 50 Years Of Innovation
    JCR Pharma Launches Into Next 50 Years Of Innovation

    17 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/sponsored/breaking-barriers-and-crossing-borders-jcr-pharma-launches-next-50-years-innovation

    FIERCE BIOTECH
    17 Nov 2025
    Share Share
    JCR Pharma Advances AAV Gene Therapy With Novel Capsid Platform
    JCR Pharma Advances AAV Gene Therapy With Novel Capsid Platform

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/jcr-pharmaceuticals-enhances-delivery-of-aav-gene-therapy-to-central-nervous-system-and-muscle-with

    PHARMIWEB
    07 Oct 2025
    Share Share
    JCR Pharmaceuticals Announces Licensing Agreement with Menagen
    JCR Pharmaceuticals Announces Licensing Agreement with Menagen

    01 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251001940655/en/JCR-Pharmaceuticals-Announces-Licensing-Agreement-with-Menagen-to-Commercialize-Agalsidase-Beta-BS-I.V.-Infusion-JCR-Across-Nine-MENAT-Markets

    BUSINESSWIRE
    01 Oct 2025
    Share Share
    Jcr Pharma To Present At Esgct 32nd Annual Congress
    Jcr Pharma To Present At Esgct 32nd Annual Congress

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250930421251/en/JCR-Pharmaceuticals-to-Present-at-the-European-Society-of-Gene-and-Cell-Therapy-ESGCT-32nd-Annual-Congress

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Japan Grants Orphan Drug Designation to JR-446 for MPS IIIB
    Japan Grants Orphan Drug Designation to JR-446 for MPS IIIB

    29 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929768776/en/Notice-of-Orphan-Drug-Designation-for-JR-446-for-Mucopolysaccharidosis-Type-IIIB-by-Ministry-of-Health-Labour-and-Welfare-of-Japan

    BUSINESSWIRE
    29 Sep 2025
    Share Share
    JCR Pharma & Alexion Hit Milestone in Neurodegenerative Program
    JCR Pharma & Alexion Hit Milestone in Neurodegenerative Program

    19 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-19/jcr-pharmaceuticals-and-alexion-achieve-milestone-in-collaborative-neurodegenerative-disease-program

    PHARMAWEB
    19 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search